GlassScriptPhysician profile
Christopher Scott Hays
NPI 1407977853
$1,513.52
in general payments reported to CMS, 2019-2025
19 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $96.81 · 2021: $125 · 2022: $93.36 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $398 · Travel and Lodging: $367 · Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $398.16 |
| Travel and Lodging | $366.88 |
| Food and Beverage | $265.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $834.83 | 2021-2025 | |
| Biogen, INC. | $96.20 | 2025 | Zurzuvae |
| Abbvie INC. | $89.76 | 2019-2022 | |
| Aspira Women'S Health INC | $72.81 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $62.67 | 2025 | Myfembree |
| Exeltis, USA INC. | $50.43 | 2020-2025 | Slynd |
| Duchesnay USA Incorporated | $48.16 | 2019 | |
| Mylan Pharmaceuticals INC. | $42.79 | 2019-2020 | |
| Scynexis, INC. | $30.63 | 2022 | |
| Organon LLC | $24.78 | 2025 | Nexplanon, Jada System |
| Therapeuticsmd, INC. | $24.36 | 2019 | |
| Ethicon US, LLC | $23.50 | 2025 | Dermabond Prineo, Vistaseal, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $18.69 | 2019 | |
| Minerva Surgical, INC | $18.66 | 2025 | |
| Millicent US INC | $18.40 | 2025 | Femlyv, Intrarosa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.56 | 2020 | |
| Lilly USA, LLC | $14.57 | 2020 | |
| Daiichi Sankyo INC. | $12.66 | 2019 | |
| Allergan, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.